We are live on ! Find out more
NXGN

NextGen Healthcare, Inc. Common Stock

Delisted

NXGN was delisted on the 8th of November, 2023.

1 hedge funds and large institutions have $24 invested in NextGen Healthcare, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 213 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2141 (-213)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $1.25B → $24 (-$1.25B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 213

Holders
1
Holders Change
-213
Holders Change %
-99.53%
% of All Funds
0.01%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
213
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

NXGN Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in NextGen Healthcare, Inc. Common Stock (NXGN) for Q4 2023, worth a combined $24 — down 100% from $1.25B a quarter earlier.

Sellers outnumbered buyers: 213 funds closed out of NXGN and 0 opened new positions — a net loss of 213 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $208M sold.

  • 1 institutional investor held NextGen Healthcare, Inc. Common Stock (NXGN) as of Q4 2023, down from 214 in Q3 2023.
  • Funds reported $24 of NextGen Healthcare, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new NextGen Healthcare, Inc. Common Stock positions in Q4 2023 and 213 closed out, a net change of -213 holders.
  • The largest NextGen Healthcare, Inc. Common Stock seller in Q4 2023 was BlackRock, an estimated $208M sold.

Based on aggregated 13F filings for Q4 2023.